Auli Ropo

1.6k total citations
46 papers, 1.2k citations indexed

About

Auli Ropo is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Auli Ropo has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Ophthalmology, 19 papers in Public Health, Environmental and Occupational Health and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Auli Ropo's work include Glaucoma and retinal disorders (34 papers), Ocular Surface and Contact Lens (19 papers) and Retinal Diseases and Treatments (14 papers). Auli Ropo is often cited by papers focused on Glaucoma and retinal disorders (34 papers), Ocular Surface and Contact Lens (19 papers) and Retinal Diseases and Treatments (14 papers). Auli Ropo collaborates with scholars based in Finland, Germany and Sweden. Auli Ropo's co-authors include Hannu Uusitalo, Kai Kaarniranta, Mika Kähönen, Pekka Ruusuvaara, Jukka Mäenpää, P Nikki, Lutz E. Pillunat, Andrew G.C. Sutton, Väinö Turjanmaa and Thomas Hamacher and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and Clinical Pharmacokinetics.

In The Last Decade

Auli Ropo

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Auli Ropo Finland	23	1.0k	639	337	121	118	46	1.2k
Jennifer S.L. Tan Australia	11	776 0.7×	65 0.1×	508 1.5×	68 0.6×	15 0.1×	12	1.1k
Hye-Jin Park South Korea	10	135 0.1×	33 0.1×	103 0.3×	28 0.2×	45 0.4×	19	501
Dipak Kumar India	11	112 0.1×	30 0.0×	38 0.1×	24 0.2×	12 0.1×	25	343
Sabah H. El-Ghaiesh Saudi Arabia	12	20 0.0×	20 0.0×	62 0.2×	27 0.2×	52 0.4×	17	568
Avisek Majumder United States	17	43 0.0×	27 0.0×	37 0.1×	48 0.4×	30 0.3×	38	566
İhsan Karslıoğlu Türkiye	12	17 0.0×	20 0.0×	150 0.4×	21 0.2×	32 0.3×	19	559
Sibel Özyazgan Türkiye	11	46 0.0×	17 0.0×	12 0.0×	52 0.4×	20 0.2×	33	344
Gregory Joseph United States	10	27 0.0×	26 0.0×	18 0.1×	25 0.2×	38 0.3×	23	354
Yufang Chen China	12	21 0.0×	18 0.0×	28 0.1×	38 0.3×	25 0.2×	36	415
Z Rymaszewski United States	12	34 0.0×	17 0.0×	25 0.1×	126 1.0×	40 0.3×	28	642

Countries citing papers authored by Auli Ropo

Since Specialization

Citations

This map shows the geographic impact of Auli Ropo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Auli Ropo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Auli Ropo more than expected).

Fields of papers citing papers by Auli Ropo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Auli Ropo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Auli Ropo. The network helps show where Auli Ropo may publish in the future.

Co-authorship network of co-authors of Auli Ropo

This figure shows the co-authorship network connecting the top 25 collaborators of Auli Ropo. A scholar is included among the top collaborators of Auli Ropo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Auli Ropo. Auli Ropo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garhöfer, Gerhard, et al.. (2025). A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension. Advances in Therapy. 42(8). 3810–3825.

Panarelli, Joseph F., Michael Tepedino, Noriko Odani‐Kawabata, et al.. (2023). Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study. Journal of Glaucoma. 32(12). 999–1005. 6 indexed citations

Kaarniranta, Kai, et al.. (2019). Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study. BMJ Open. 9(4). e024129–e024129. 23 indexed citations

Ropo, Auli, et al.. (2018). IOP lowering effect of omidenepag isopropyl in latanoprost non-/low-responder subjects with primary open-angle glaucoma or ocular hypertension: the FUJI study. Investigative Ophthalmology & Visual Science. 59(9). 1233–1233. 2 indexed citations

Kaarniranta, Kai, et al.. (2015). Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015 % and Timolol 0.5 % in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies. Clinical Pharmacokinetics. 55(4). 485–494. 16 indexed citations

Holló, Gábor, et al.. (2014). Efficacy, Safety, and Tolerability of Preservative-Free Fixed Combination of Tafluprost 0.0015%/Timolol 0.5% Versus Concomitant Use of the Ingredients. Journal of Ocular Pharmacology and Therapeutics. 30(6). 468–475. 39 indexed citations

Pfeiffer, Norbert, Carlo Enrico Traverso, Katrin Lorenz, et al.. (2014). A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components. Advances in Therapy. 31(12). 1228–1246. 35 indexed citations

Holló, Gábor, Jouni Vuorinen, Juhani Tuominen, et al.. (2014). Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products. Advances in Therapy. 31(9). 932–944. 32 indexed citations

Latvala, Terho, et al.. (2010). Handling Test of Eye Drop Dispenser—Comparison of Unit-Dose Pipettes with Conventional Eye Drop Bottles. Journal of Ocular Pharmacology and Therapeutics. 26(3). 273–276. 16 indexed citations

10.

Traverso, Carlo Enrico, Auli Ropo, Marina Papadia, & Hannu Uusitalo. (2010). A Phase II Study on the Duration and Stability of the Intraocular Pressure-Lowering Effect and Tolerability of Tafluprost Compared With Latanoprost. Journal of Ocular Pharmacology and Therapeutics. 26(1). 97–104. 45 indexed citations

11.

Mäenpää, Jukka, Hannu Kautiainen, Ari Tolonen, et al.. (2008). Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor. European Journal of Pharmaceutical Sciences. 36(2-3). 292–296. 19 indexed citations

12.

Uusitalo, Hannu, Kai Kaarniranta, & Auli Ropo. (2008). Pharmacokinetics, efficacy and safety profiles of preserved and preservative‐free tafluprost in healthy volunteers. Acta Ophthalmologica. 86(s242). 7–13. 49 indexed citations

13.

Sutton, Andrew G.C., Pieter Gouws, & Auli Ropo. (2008). Tafluprost, a new potent prostanoid receptor agonist: a dose-response study on pharmacodynamics and tolerability in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 46(8). 400–406. 25 indexed citations

14.

Sutton, Andrew G.C., et al.. (2007). A Comparative, Placebo-Controlled Study of Prostanoid Fluoroprostaglandin-Receptor Agonists Tafluprost and Latanoprost in Healthy Males. Journal of Ocular Pharmacology and Therapeutics. 23(4). 359–365. 40 indexed citations

15.

Papadia, Marina, Carlo Enrico Traverso, Auli Ropo, & Hannu Uusitalo. (2006). A Pilot Phase Ii Study On The Extent, Duration Of Action And Stability Of The Iop Lowering Effect Of Tafluprost 0.0015%, A Novel Prostaglandin Analogue, As Compared To Latanoprost 0.005%. Investigative Ophthalmology & Visual Science. 47(13). 447–447. 1 indexed citations

16.

Uusitalo, Hannu, Mika Kähönen, Auli Ropo, et al.. (2006). Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma. Graefe s Archive for Clinical and Experimental Ophthalmology. 244(11). 1491–1496. 32 indexed citations

17.

Nieminen, Tuomo, Terho Lehtimäki, Jukka Mäenpää, et al.. (2006). Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effects. Scandinavian Journal of Clinical and Laboratory Investigation. 67(2). 237–245. 76 indexed citations

18.

Ropo, Auli, et al.. (2004). A Comparative Trial of the Safety and Efficacy of 0.1 Percent Pemirolast Potassium Ophthalmic Solution Dosed Twice or Four Times a Day in Patients with Seasonal Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 20(2). 139–150. 6 indexed citations

19.

Ruusuvaara, Pekka, et al.. (1995). Comparison of etidocaine and bupivacaine + lidocaine in retrobulbar anaesthesia. Acta Ophthalmologica Scandinavica. 73(6). 563–566. 1 indexed citations

20.

Ropo, Auli, Pekka Ruusuvaara, & P Nikki. (1992). Ptosis following periocular or general anaesthesia in cataract surgery. Acta Ophthalmologica. 70(2). 262–265. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact